secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED GUARDIAN INC (UG)
CIK:        0000101295
Form:       8-K
Filed at:   2025-08-08T23:59:59+00:00
Accession:  0001171843-25-005206
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United-Guardian Q2 net sales fall 16% YoY; EPS $0.14 vs $0.21
-------------------------------------------------------------

- Q2 net sales $2.84M, down 16% YoY from $3.39M; net income $627K ($0.14) vs $956K ($0.21).
- H1 net sales $5.32M, down 20% YoY; net income $1.19M ($0.26) vs $1.88M ($0.41).
- Medical lubricants +12% and pharmaceuticals +11% in H1; cosmetic sales fell due to ASI inventory overstock in Asia.
- Q2 sequential improvement: sales +14% and net income +12% vs Q1 2025.
- Company pursuing Renacidin formulary expansion to boost pharmaceutical sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/101295/000117184325005206/0001171843-25-005206-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/101295/000117184325005206/f8k_080725.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-005206

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer